PML and PML nuclear bodies: implications in antiviral defence.
暂无分享,去创建一个
[1] P. Pearson,et al. Atmospheric carbon dioxide concentrations over the past 60 million years , 2000, Nature.
[2] G. Maul,et al. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot , 2001, Oncogene.
[3] Yongsok Kim,et al. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Everett,et al. Interactions between DNA viruses, ND10 and the DNA damage response , 2006, Cellular microbiology.
[5] C. Boutell,et al. Herpes Simplex Virus Type 1 Immediate-Early Protein ICP0 and Its Isolated RING Finger Domain Act as Ubiquitin E3 Ligases In Vitro , 2002, Journal of Virology.
[6] R. Bristow,et al. Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR , 2006, The Journal of cell biology.
[7] Paul Freemont,et al. Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as2O3-Induced Pml or Pml/Retinoic Acid Receptor α Degradation , 2001, The Journal of experimental medicine.
[8] H. Will,et al. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. , 1990, Journal of immunology.
[9] T. Regad,et al. Role and fate of PML nuclear bodies in response to interferon and viral infections , 2001, Oncogene.
[10] A. Goryachev,et al. Herpes Simplex Virus Triggers and Then Disarms a Host Antiviral Response , 2001, Journal of Virology.
[11] A. Tyner,et al. Functional analysis and intracellular localization of p53 modified by SUMO-1 , 2001, Oncogene.
[12] G. Dellaire,et al. Chromatin Contributes to Structural Integrity of Promyelocytic Leukemia Bodies through a SUMO-1-independent Mechanism* , 2004, Journal of Biological Chemistry.
[13] O. Jänne,et al. PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases , 2002, Molecular and Cellular Biology.
[14] Mounira K Chelbi-Alix,et al. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins , 1999, Oncogene.
[15] S. Günther,et al. Inhibition of Different Lassa Virus Strains by Alpha and Gamma Interferons and Comparison with a Less Pathogenic Arenavirus , 2004, Journal of Virology.
[16] M. Weitzman,et al. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. , 1996, Genes & development.
[17] K. Wilcox,et al. SP100B is a repressor of gene expression , 2005, Journal of cellular biochemistry.
[18] A. Dejean,et al. SUMO: of branched proteins and nuclear bodies , 2001, Oncogene.
[19] M. Ruberg,et al. PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins , 2006, The Journal of cell biology.
[20] A. Harman,et al. Activation of Interferon Response Factor-3 in Human Cells Infected with Herpes Simplex Virus Type 1 or Human Cytomegalovirus , 2001, Journal of Virology.
[21] R. Hay,et al. SUMO: a history of modification. , 2005, Molecular cell.
[22] Pier Paolo Pandolfi,et al. The transcriptional role of PML and the nuclear body , 2000, Nature Cell Biology.
[23] R. van Driel,et al. Cell cycle regulation of PML modification and ND10 composition. , 1999, Journal of cell science.
[24] M. Carmo-Fonseca,et al. Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome. , 2002, Molecular biology of the cell.
[25] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[26] M. Weitzman,et al. Serotype-Specific Reorganization of the Mre11 Complex by Adenoviral E4orf3 Proteins , 2005, Journal of Virology.
[27] Graham Dellaire,et al. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[28] L. Enquist,et al. Pseudorabies Virus EP0 Protein Counteracts an Interferon-Induced Antiviral State in a Species-Specific Manner , 2006, Journal of Virology.
[29] K. Leppard,et al. Interaction of the Adenovirus Type 5 E4 Orf3 Protein with Promyelocytic Leukemia Protein Isoform II Is Required for ND10 Disruption , 2006, Journal of Virology.
[30] A. Dejean,et al. Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.
[31] E. Kieff,et al. Mediation of Epstein–Barr virus EBNA‐LP transcriptional coactivation by Sp100 , 2005, The EMBO journal.
[32] K. Nagata,et al. Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus. , 2005, Virology.
[33] Adrian A Canutescu,et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. , 2005, Developmental cell.
[34] P. Pandolfi,et al. PML mediates the interferon‐induced antiviral state against a complex retrovirus via its association with the viral transactivator , 2001, The EMBO journal.
[35] K. Conzelmann,et al. Mapping the Interacting Domains between the Rabies Virus Polymerase and Phosphoprotein , 1998, Journal of Virology.
[36] R. Everett. ICP0, a regulator of herpes simplex virus during lytic and latent infection. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[37] T. Sternsdorf,et al. The Nuclear Dot Protein Sp100, Characterization of Domains Necessary for Dimerization, Subcellular Localization, and Modification by Small Ubiquitin-like Modifiers* , 1999, The Journal of Biological Chemistry.
[38] K. Borden,et al. Two RING Finger Proteins, the Oncoprotein PML and the Arenavirus Z Protein, Colocalize with the Nuclear Fraction of the Ribosomal P Proteins , 1998, Journal of Virology.
[39] P. Freemont,et al. PML protein isoforms and the RBCC/TRIM motif , 2001, Oncogene.
[40] A. Dejean,et al. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] N. DeLuca,et al. Herpes Simplex Virus 1 Has Multiple Mechanisms for Blocking Virus-Induced Interferon Production , 2004, Journal of Virology.
[42] G. Hayward,et al. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. , 2000, Virology.
[43] D. Blondel,et al. Rabies Virus P Protein Interacts with STAT1 and Inhibits Interferon Signal Transduction Pathways , 2005, Journal of Virology.
[44] H. de Thé,et al. Resistance to Virus Infection Conferred by the Interferon-Induced Promyelocytic Leukemia Protein , 1998, Journal of Virology.
[45] P. Pandolfi,et al. Promyelocytic Leukemia Protein Mediates Interferon-Based Anti-Herpes Simplex Virus 1 Effects , 2003, Journal of Virology.
[46] R. Everett,et al. ND10 Components Relocate to Sites Associated with Herpes Simplex Virus Type 1 Nucleoprotein Complexes during Virus Infection , 2005, Journal of Virology.
[47] A. García-Sastre,et al. Inhibition of the Type I Interferon Response by the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus , 2006, Journal of Virology.
[48] A. Wyllie,et al. Stress responses of PML nuclear domains are ablated by ataxin‐1 and other nucleoprotein inclusions , 2004, The Journal of pathology.
[49] H. de Thé,et al. Induction of the PML protein by interferons in normal and APL cells. , 1995, Leukemia.
[50] M. Weidman,et al. Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity. , 2001, Virology.
[51] D. Blondel,et al. Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[52] T. Sternsdorf,et al. Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif. , 1999, Journal of cell science.
[53] P. Pandolfi,et al. Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies. , 2004, The Journal of general virology.
[54] W. Bresnahan,et al. Human Cytomegalovirus (HCMV) UL82 Gene Product (pp71) Relieves hDaxx-Mediated Repression of HCMV Replication , 2006, Journal of Virology.
[55] T. Bächi,et al. Spatial and Temporal Organization of Adeno-Associated Virus DNA Replication in Live Cells , 2004, Journal of Virology.
[56] H. Will,et al. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. , 1992, Journal of immunology.
[57] P. Pandolfi,et al. Role of PML in cell growth and the retinoic acid pathway. , 1998, Science.
[58] P. Pandolfi,et al. Cytoplasmic PML function in TGF-β signalling , 2004, Nature.
[59] Christopher H Eskiw,et al. PML bodies: a meeting place for genomic loci? , 2005, Journal of Cell Science.
[60] T. Mizutani,et al. Promyelocytic Leukemia Protein Is Redistributed during the Formation of Intranuclear Inclusions Independent of Polyglutamine Expansion: An Immunohistochemical Study on Marinesco Bodies , 2002, Journal of neuropathology and experimental neurology.
[61] R. Everett,et al. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. , 1996, Virology.
[62] T. Stamminger,et al. Evidence for a Role of the Cellular ND10 Protein PML in Mediating Intrinsic Immunity against Human Cytomegalovirus Infections , 2006, Journal of Virology.
[63] G. Maul,et al. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition , 1996, The Journal of cell biology.
[64] M. Goldsmith,et al. JAK/STAT signaling by cytokine receptors. , 1998, Current opinion in immunology.
[65] E. Yeh,et al. Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1 , 1999, The Journal of cell biology.
[66] Hideo Negishi,et al. Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence , 2003, Nature.
[67] P. Lønning,et al. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA , 2006, Journal of Cell Science.
[68] R. Bartenschlager,et al. Replication of the hepatitis C virus in cell culture. , 2003, Antiviral research.
[69] H. Tanke,et al. Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. , 2002, Journal of structural biology.
[70] N. DeLuca,et al. Expression of Herpes Simplex Virus ICP0 Inhibits the Induction of Interferon-Stimulated Genes by Viral Infection , 2002, Journal of Virology.
[71] P. Pandolfi,et al. A role for PML and the nuclear body in genomic stability , 1999, Oncogene.
[72] E. Sztul,et al. Nuclear aggresomes form by fusion of PML-associated aggregates. , 2005, Molecular biology of the cell.
[73] S. Lowe,et al. PML is induced by oncogenic ras and promotes premature senescence. , 2000, Genes & development.
[74] P. Pandolfi,et al. Role of PML and the PML-nuclear body in the control of programmed cell death , 2003, Oncogene.
[75] L. Zon,et al. SUMO-1 protease-1 regulates gene transcription through PML. , 2002, Molecular cell.
[76] T. Sternsdorf,et al. Nuclear dots: actors on many stages. , 1997, Immunobiology.
[77] P. Pelicci,et al. PML interaction with p53 and its role in apoptosis and replicative senescence , 2001, Oncogene.
[78] Alessandro Guffanti,et al. The tripartite motif family identifies cell compartments , 2001, The EMBO journal.
[79] P. Pandolfi,et al. Regulation of p53 activity in nuclear bodies by a specific PML isoform , 2000, The EMBO journal.
[80] K. Wilcox,et al. SP100B, a repressor of gene expression preferentially binds to DNA with unmethylated CpGs , 2006, Journal of cellular biochemistry.
[81] Nicholas J. McGlincy,et al. Isoforms of the promyelocytic leukemia protein differ in their effects on ND10 organization. , 2005, Experimental cell research.
[82] E. Réal,et al. Functional Interaction Map of Lyssavirus Phosphoprotein: Identification of the Minimal Transcription Domains , 2001, Journal of Virology.
[83] Ailan Guo,et al. The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.
[84] A. Dejean,et al. Deconstructing PML‐induced premature senescence , 2002, The EMBO journal.
[85] K. Mossman,et al. Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon , 2000, Journal of Virology.
[86] Mark R. Soboleski,et al. ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency , 2006, Virology Journal.
[87] N. Perkins,et al. P300 transcriptional repression is mediated by SUMO modification. , 2003, Molecular cell.
[88] S. Minucci,et al. PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage , 2002, Oncogene.
[89] P. Freemont,et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto‐oncoprotein PML. , 1995, The EMBO journal.
[90] B. Roizman,et al. Role of ICP0 in the Strategy of Conquest of the Host Cell by Herpes Simplex Virus 1 , 2004, Journal of Virology.
[91] L. Bruhn,et al. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. , 2001, Genes & development.
[92] Pier Paolo Pandolfi,et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras , 2000, Nature.
[93] C. Higgins,et al. Role for Centromeric Heterochromatin and PML Nuclear Bodies in the Cellular Response to Foreign DNA , 2006, Molecular and Cellular Biology.
[94] M. J. Nicholl,et al. Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. , 2006, The Journal of general virology.
[95] P. Pandolfi,et al. Effects of Promyelocytic Leukemia Protein on Virus-Host Balance , 2002, Journal of Virology.
[96] R. Hay,et al. SUMO‐1 modification activates the transcriptional response of p53 , 1999, The EMBO journal.
[97] P. Thomas,et al. Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. , 2001, Journal of cell science.
[98] A. Saïb,et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. , 1995, Oncogene.
[99] R. Kalejta,et al. Inactivating a Cellular Intrinsic Immune Defense Mediated by Daxx Is the Mechanism through Which the Human Cytomegalovirus pp71 Protein Stimulates Viral Immediate-Early Gene Expression , 2006, Journal of Virology.
[100] R. Reddel,et al. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. , 1999, Cancer research.
[101] C. Paulus,et al. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[102] G. Kochs,et al. Inverse interference: how viruses fight the interferon system. , 2004, Viral immunology.
[103] T. Gibson,et al. The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation , 2001, Nature Structural Biology.
[104] H. de Thé,et al. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[105] P. Pandolfi,et al. Pml is essential for multiple apoptotic pathways , 1998, Nature Genetics.
[106] R. Everett,et al. DNA viruses and viral proteins that interact with PML nuclear bodies , 2001, Oncogene.
[107] Y. Percherancier,et al. Cross Talk between PML and p53 during Poliovirus Infection: Implications for Antiviral Defense , 2006, Journal of Virology.
[108] M. Mitchell,et al. PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase , 2006, Journal of Cell Science.
[109] S. Goodbourn,et al. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.
[110] C. Boutell,et al. Phenotype of a Herpes Simplex Virus Type 1 Mutant That Fails To Express Immediate-Early Regulatory Protein ICP0 , 2004, Journal of Virology.
[111] G. Maul. Nuclear domain 10, the site of DNA virus transcription and replication , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[112] Ari Helenius,et al. How Viruses Enter Animal Cells , 2004, Science.
[113] P. Lopez,et al. Overexpression of Promyelocytic Leukemia Protein Precludes the Dispersal of ND10 Structures and Has No Effect on Accumulation of Infectious Herpes Simplex Virus 1 or Its Proteins , 2002, Journal of Virology.
[114] J. Milner,et al. Specific DNA binding by different classes of human p53 mutants. , 1995, Oncogene.
[115] T. Gilliam,et al. Differential SMN2 expression associated with SMA severity , 1998, Nature Genetics.
[116] S. Finke,et al. Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.
[117] R. Everett,et al. PML Contributes to a Cellular Mechanism of Repression of Herpes Simplex Virus Type 1 Infection That Is Inactivated by ICP0 , 2006, Journal of Virology.
[118] L. Espert,et al. Interferons α and γ induce p53-dependent and p53-independent apoptosis, respectively , 2005, Oncogene.
[119] H. de Thé,et al. Characterization of endogenous human promyelocytic leukemia isoforms. , 2006, Cancer research.
[120] P. Galle,et al. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. , 2005, Cancer research.
[121] Eui Tae Kim,et al. Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein. , 2006, The Journal of general virology.
[122] T. Sternsdorf,et al. Evidence for Covalent Modification of the Nuclear Dot–associated Proteins PML and Sp100 by PIC1/SUMO-1 , 1997, The Journal of cell biology.
[123] A. Ivanov,et al. Differential Role of Sp100 Isoforms in Interferon-Mediated Repression of Herpes Simplex Virus Type 1 Immediate-Early Protein Expression , 2006, Journal of Virology.
[124] D. Hilton,et al. Inhibitors of Cytokine Signal Transduction* , 2004, Journal of Biological Chemistry.
[125] K. Jensen,et al. The Interferon (IFN)-stimulated Gene Sp100 Promoter Contains an IFN-γ Activation Site and an Imperfect IFN-stimulated Response Element Which Mediate Type I IFN Inducibility* , 1996, The Journal of Biological Chemistry.
[126] W. Halford,et al. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. , 2002, Virology.
[127] J. Yewdell,et al. Intracellular Localization of Proteasomal Degradation of a Viral Antigen , 1999, The Journal of cell biology.
[128] Pier Paolo Pandolfi,et al. The Role of PML in Tumor Suppression , 2002, Cell.
[129] P. Lieberman,et al. Lytic but Not Latent Replication of Epstein-Barr Virus Is Associated with PML and Induces Sequential Release of Nuclear Domain 10 Proteins , 2000, Journal of Virology.
[130] R. Everett,et al. Alphaherpesvirus Proteins Related to Herpes Simplex Virus Type 1 ICP0 Affect Cellular Structures and Proteins , 2000, Journal of Virology.
[131] P. Pandolfi,et al. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies , 2002, Oncogene.
[132] G. Maul,et al. Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX , 2004, Journal of Cell Science.
[133] P. Pandolfi,et al. Role of the Promyelocytic Leukemia Protein PML in the Interferon Sensitivity of Lymphocytic Choriomeningitis Virus , 2001, Journal of Virology.
[134] Clinton Jones,et al. The Bovine herpesvirus 1 gene encoding infected cell protein 0 (bICP0) can inhibit interferon-dependent transcription in the absence of other viral genes. , 2005, The Journal of general virology.
[135] E. Blanchard,et al. Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus , 2006, Journal of Virology.
[136] A. Dasgupta,et al. Nuclear entry of poliovirus protease-polymerase precursor 3CD: implications for host cell transcription shut-off. , 2004, Virology.
[137] C. Lilley,et al. The Mre11 complex is required for ATM activation and the G2/M checkpoint , 2003, The EMBO journal.
[138] G. Grosveld,et al. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. , 2002, Journal of cell science.